Published in Can J Infect Dis on January 01, 2002
Levofloxacin-induced acute anxiety and insomnia. J Neurosci Rural Pract (2012) 1.10
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol (2015) 0.92
Permanent Peripheral Neuropathy: A Case Report on a Rare but Serious Debilitating Side-Effect of Fluoroquinolone Administration. J Investig Med High Impact Case Rep (2014) 0.75
Use of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumonia. Curr Ther Res Clin Exp (2004) 0.75
A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain. Saudi Pharm J (2013) 0.75
Moxifloxacin-induced acute psychosis: A case report with literature review. J Res Pharm Pract (2016) 0.75
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. Mil Med (2017) 0.75
1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS. J Med Pharm Chem (1962) 13.97
New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis (2000) 3.45
Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother (1994) 3.20
The chemistry and biological profile of trovafloxacin. J Antimicrob Chemother (1997) 1.65
Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones. Antimicrob Agents Chemother (1999) 1.63
Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol (1995) 1.59
Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf (1999) 1.53
Reassuring safety profile of moxifloxacin. Clin Infect Dis (2001) 1.52
Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf (1995) 1.43
Temafloxacin syndrome: review of 95 cases. Clin Infect Dis (1994) 1.19
Quinolone-induced QT interval prolongation: a not-so-unexpected class effect. J Antimicrob Chemother (2000) 1.16
Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin. Am J Med (1990) 1.12
The withdrawal of temafloxacin. Are there implications for other quinolones? Drug Saf (1993) 1.11
Classification and structure-activity relationships of fluoroquinolones. Drugs (1995) 1.06
Fluoroquinolone toxicities. An update. Drugs (1995) 1.01
Acute eosinophilic hepatitis from trovafloxacin. N Engl J Med (2000) 0.95
QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin. Am J Med (1999) 0.94
Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother (2000) 0.93
Quinolones: structure-activity relationships and future predictions. J Med Microbiol (1996) 0.89
Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers. J Antimicrob Chemother (1999) 0.88
Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1991) 0.85
Clinical features and management of adverse effects of quinolone antibacterials. Drug Saf (1991) 0.84
Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources. Arch Dermatol Res (1996) 0.84
Persistence of neurosyphilis despite multiple treatment regimens. Am J Med (1989) 0.84
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience. Int J Clin Pract (2001) 0.83
Fluoroquinolones as a cause of tendon disorders in patients with renal failure/renal transplants. Br J Rheumatol (1998) 0.81
Torsades de pointe probably related to sparfloxacin. Eur J Clin Microbiol Infect Dis (1996) 0.81
Quinolone antibacterials: a new class of photochemical carcinogens. J Photochem Photobiol B (1997) 0.80
Tendons and fluoroquinolones. Unresolved issues. Rev Rhum Engl Ed (1997) 0.78
Fluoroquinolones in urinary tract infections. Proper and improper use. Drugs (1996) 0.78
[Is hemodialysis a risk factor for tendinopathies due to fluoroquinolones?]. Therapie (1998) 0.78
Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives. Pharm Weekbl Sci (1989) 0.78
Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf (1999) 1.53
Reassuring safety profile of moxifloxacin. Clin Infect Dis (2001) 1.52
Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf (1995) 1.43
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis (1996) 1.40
MIC audit for routine ciprofloxacin sensitivity testing. J Antimicrob Chemother (1993) 1.39
Acute infective exacerbations of chronic bronchitis. QJM (1995) 1.33
Therapeutic advances of new fluoroquinolones. Expert Opin Investig Drugs (1998) 1.31
Evaluation of the clinical microbiology profile of moxifloxacin. Clin Infect Dis (2001) 1.03
Use of ciprofloxacin in developing countries. Pediatr Infect Dis J (1997) 0.91
Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activity. Clin Infect Dis (2001) 0.89
Antimicrobial safety and tolerability: differences and dilemmas. Clin Infect Dis (2001) 0.89
Early diagnosis of spinal cord arteriovenous malformation in a 7-year-old child. Clin Pediatr (Phila) (1994) 0.85
Haemophilus parainfluenzae infection of respiratory mucosa. Respir Med (2003) 0.84
Methicillin-resistant Staphylococcus aureus (MRSA) in the community. Lancet (1995) 0.84
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience. Int J Clin Pract (2001) 0.83
A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context. Int J Antimicrob Agents (2004) 0.82
Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother (1994) 0.81
Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Rhinosinusitis Investigation Group. Clin Ther (1999) 0.80
Delayed hypersensitivity skin testing does not influence the management of surgical patients. Ann Surg (1982) 0.80
Prevention of sepsis following endoscopic retrograde cholangiopancreatography. J Hosp Infect (1991) 0.79
Pharmacokinetics of orally administered ciprofloxacin in abdominal surgery. Am J Med (1989) 0.78
Chemotherapy for chronic bronchitis. Controversies. Presse Med (1995) 0.78
High dose parenteral ciprofloxacin in pleuro-pulmonary disease: a comparative pharmacolinetics of 400 and 200 mg intravenous. Int J Antimicrob Agents (1997) 0.75
Clinical studies in chronic bronchitis: a need for better definition and classification of severity. J Antimicrob Chemother (1996) 0.75
The effects of low concentrations of antibiotics on epithelial damage caused by non-typable Haemophilus influenzae and bacterial morphology. J Antimicrob Chemother (1995) 0.75
Studies on regulation of pancreatic gastrin gene to analyze the mechanisms of islet cell differentiation during fetal development. Z Gastroenterol Verh (1991) 0.75
Geminofloxacin for the management of community-acquired respiratory tract infections. J Chemother (2006) 0.75
Sequential antimicrobial therapy--the role of quinolones. J Antimicrob Chemother (1997) 0.75